Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma [PDF]
Background: Hepatocellular carcinoma (HCC) is the third most common cause of cancer deaths. Difficulties to diagnose HCC at early stages remain the major obstacle to curative (surgical) therapy. Therapy in advanced stages has to be considered palliative.
Forstpointner, Roswitha +6 more
core +1 more source
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. [PDF]
The main objectives of this study were to define the occurrence and levels of hepatitis B virus (HBV) DNA in asymptomatic HBV carriers, cirrhosis patients and hepatocellular carcinoma (HCC) cases from The Gambia, and to evaluate the risk for cirrhosis or
Whittle, H +23 more
core +1 more source
Portal vein thrombosis and arterioportal shunts : effects on tumor response after chemoembolization of hepatocellular carcinoma [PDF]
AIM: To evaluate the effect of portal vein thrombosis and arterioportal shunts on local tumor response in advanced cases of unresectable hepatocellular carcinoma treated by transarterial chemoembolization.
Ackermann, Hans +6 more
core +1 more source
Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma [PDF]
AIM: The heptadecapeptide nociceptin alias orphanin FQ is the endogenous agonist of opioid receptor-like1 receptor. It is involved in modulation of pain and cognition.
Horváth, Andrea +7 more
core +2 more sources
Research Progress of DUB Enzyme in Hepatocellular Carcinoma
According to GLOBOCAN 2021 cancer incidence and mortality statistics compiled by the International Agency for Research on Cancer, hepatocellular carcinoma (HCC) is the most common malignancy in the human liver and one of the leading causes of cancer ...
Jie Zhao +13 more
doaj +1 more source
Treatment of Hepatocellular Carcinoma (HCC)
Hepatocellular carcinoma (HCC) or hepatoma is the most common type of primary liver cancer, followed by malignant lymphoma, fibrosarcoma, and hemangioendotelioma. In high-incidence areas, the most common cause is HBV transmitted at birth, and HCC is diagnosed about a decade earlier than in North America and Europe, where the most common etiology is HCV
Christian Martin +3 more
openaire +1 more source
Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms
On the global scale, hepatitis B virus (HBV) infection is the main cause of hepatocellular carcinoma (HCC) especially in regions of Asia where HBV infection is endemic.
Bo Zheng +3 more
semanticscholar +1 more source
Innovative treatment for hepatocellular carcinoma (HCC) [PDF]
Indocyanine green (ICG) is not new in the field of liver surgery. Early studies performed in the 1980s and 1990s revealed the value of the ICG clearance test in predicting post-hepatectomy morbidity and mortality. ICG clearance and retention tests are crucial for determining precise liver function before liver surgery and offer several benefits for ...
Junichi, Kaneko +3 more
openaire +2 more sources
Unusual Presentation of Hepatocellular Carcinoma into Right iliac fossa: A Rare Entity [PDF]
Hepatocellular carcinoma (HCC) is the most common primary malignant hepatic tumour. Hepatocellular carcinoma presenting itself or extending into the right iliac fossa (RIF) is a very rare entity. We report on a rare case of hepatocellular carcinoma in a
Murali Uthamalingam +1 more
doaj +1 more source
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development [PDF]
Background: Vitamin D insufficiency has been associated with the occurrence of various types of cancer, but causal relationships remain elusive. We therefore aimed to determine the relationship between genetic determinants of vitamin D serum levels and ...
Jörg Bojunga +127 more
core +3 more sources

